11.1 Electronic Fetal Monitoring (EFM): Baseline, Variability, Decelerations & Categories
Key Takeaways
Uterine activity quantification requires evaluating contraction frequency, duration, intensity, and resting tone; uterine tachysystole is strictly defined as >5 contractions in 10 minutes averaged over a 30-minute window, with or without associated fetal heart rate decelerations.
Baseline fetal heart rate is normally 110–160 bpm; baseline variability reflects the dynamic balance between sympathetic and parasympathetic autonomic inputs, with moderate variability (6–25 bpm) serving as the single most reliable clinical indicator of an intact fetal central nervous system and absence of severe metabolic acidemia.
Fetal heart rate decelerations reflect distinct pathophysiological mechanisms: early decelerations stem from vagal stimulation due to transient fetal head compression (benign); late decelerations reflect uteroplacental insufficiency and transient fetal hypoxemia; variable decelerations indicate umbilical cord compression; and a sinusoidal pattern indicates critical fetal anemia or severe fetomaternal hemorrhage.
The NICHD Three-Tier FHR Interpretation System stratifies tracings into Category I (normal, strongly predictive of normal fetal acid-base status), Category II (indeterminate, requiring continuous surveillance, intrauterine resuscitation, and reevaluation), and Category III (abnormal acid-base status, requiring immediate intrauterine resuscitation and prompt delivery if uncorrected).
Evidence-based intrauterine resuscitation protocols employ a rapid multi-step bundle: lateral maternal repositioning to alleviate aortocaval compression, rapid intravenous crystalloid fluid bolus (500–1000 mL), supplemental oxygen only for documented maternal hypoxemia, discontinuation of uterotonics, administration of subcutaneous terbutaline (0.25 mg) for tachysystole, and amnioinfusion for recurrent variable decelerations.
Electronic Fetal Monitoring (EFM): Baseline, Variability, Decelerations & Categories
Intrapartum electronic fetal monitoring (EFM) evaluates fetal oxygenation and acid-base status during labor. The goal is to detect progressive fetal hypoxemia and acidemia early, enabling interventions that prevent hypoxic-ischemic encephalopathy (HIE) or demise while avoiding unnecessary operative delivery.
Surveillance Modalities & Uterine Activity Assessment
Surveillance modalities include intermittent auscultation (IA) via Doppler or Pinard stethoscope (for low-risk pregnancies: every 15–30 min in active first stage, every 5–15 min in second stage) and continuous EFM. Continuous monitoring combines an external ultrasound transducer with a tocodynamometer. When external tracings are unreliable, internal options include the fetal spiral electrode (FSE) (direct R-wave tracking; contraindicated in maternal HIV, hepatitis B/C, active genital HSV, or fetal coagulopathy) and the intrauterine pressure catheter (IUPC), which quantifies contractions in millimeters of mercury (mm Hg) and calculates Montevideo Units (MVUs).
Uterine activity assessment measures contraction frequency, duration, intensity, and resting tone (normal: 8–15 mm Hg):
- Normal Uterine Activity: <=5 contractions in 10 minutes, averaged over 30 minutes.
- Uterine Tachysystole: >5 contractions in 10 minutes averaged over 30 minutes, with or without fetal heart rate (FHR) decelerations. Excessive contraction frequency restricts intervillous blood flow, depleting fetal oxygen reserves and leading to metabolic acidemia.
Important
Historical terms like "hyperstimulation" and "hypertonus" are obsolete. Clinicians must use uterine tachysystole, qualifying it by etiology (spontaneous vs. induced) and presence of decelerations.
FHR Baseline, Variability & Accelerations
Standardized NICHD definitions guide the interpretation of fetal heart rate patterns:
- Baseline FHR: Mean heart rate rounded to 5 bpm increments over 10 minutes (excluding periodic changes and marked variability; must be present for >=2 minutes). Normal range is 110 to 160 bpm.
- Tachycardia (>160 bpm for >=10 min): Caused by maternal intraamniotic infection/chorioamnionitis, maternal fever, medications (terbutaline, atropine), illicit stimulants, or early compensatory hypoxemia.
- Bradycardia (<110 bpm for >=10 min): Caused by maternal hypotension (post-epidural), cord prolapse, rapid descent, congenital complete heart block (anti-Ro/SSA antibodies), or terminal acidemia.
- Baseline Variability: Fluctuations in baseline FHR, reflecting autonomic sympathetic-parasympathetic interplay:
- Absent: Undetectable amplitude; indicates severe metabolic acidemia or structural injury.
- Minimal (<=5 bpm): Caused by fetal sleep cycles (typically 20–40 min), CNS depressants (opioids, magnesium sulfate), prematurity, or developing acidemia.
- Moderate (6 to 25 bpm): Gold standard indicator of an intact, oxygenated central nervous system; reliably rules out fetal metabolic acidemia.
- Marked (>25 bpm): Often an acute compensatory response to transient stress or acute cord compression.
- Accelerations: Abrupt increase in FHR (onset to peak <30 sec). At >=32 weeks, peak >=15 bpm above baseline lasting >=15 seconds. At <32 weeks, peak >=10 bpm lasting >=10 seconds. Spontaneous or stimulated accelerations reliably indicate a cord arterial pH >7.20.
Decelerations & Pattern Morphology
| Deceleration Type | Timing & Morphology | Pathophysiologic Mechanism | Clinical Significance & Action |
|---|---|---|---|
| Early Deceleration | Gradual decrease (onset to nadir >=30 sec) symmetrically mirroring the contraction; nadir matches contraction peak. | Fetal head compression stimulating vagal parasympathetic discharge. | Benign physiologic event. No hypoxemia or acidemia; expectant management without intervention. |
| Late Deceleration | Gradual decrease (onset to nadir >=30 sec) with onset, nadir, and recovery occurring after contraction onset, peak, and end. | Uteroplacental insufficiency with transient fetal hypoxemia below critical PaO2 (<15–18 mm Hg). | Non-reassuring pathologic sign. Indicates fetal hypoxia; requires immediate intrauterine resuscitation. |
| Variable Deceleration | Abrupt drop (onset to nadir <30 sec) >=15 bpm lasting >=15 sec but <2 min; sharp V-shape with preceding/following "shoulders." | Umbilical cord compression causing increased afterload and baroreceptor-mediated vagal slowing. | Common in labor. Atypical features (loss of variability, slow recovery) portend acidemia. Treat with repositioning/amnioinfusion. |
| Prolonged Deceleration | Decrease in FHR >=15 bpm lasting >=2 minutes but <10 minutes. | Sustained oxygenation disruption (cord prolapse, tachysystole, maternal hypotension, abruption). | Emergent clinical crisis. If >=10 minutes, classified as bradycardia, requiring rapid delivery if unresolved. |
| Sinusoidal Pattern | Smooth, undulating sine wave (3–5 cycles/min) lasting >=20 minutes, devoid of accelerations. | Severe fetal anemia, fetomaternal hemorrhage, Rh alloimmunization, or twin-to-twin transfusion. | Category III pattern. Severe compromise requiring immediate delivery or intrauterine blood transfusion. |
NICHD Three-Tier Interpretation System
- Category I (Normal): Requires baseline 110–160 bpm, moderate variability, absence of late/variable decelerations, early decelerations present or absent, and accelerations present or absent. Strongly predictive of normal fetal acid-base status; manage expectantly.
- Category II (Indeterminate): All tracings not meeting Category I or III (e.g., minimal variability, marked variability, absent accelerations, recurrent variable decelerations with moderate variability, prolonged decelerations). Not predictive of abnormal acid-base status; mandates continuous monitoring, intrauterine resuscitation, and reevaluation.
- Category III (Abnormal): Demonstrates absent baseline variability PLUS recurrent late decelerations, recurrent variable decelerations, or bradycardia; OR a sinusoidal pattern. Predictive of abnormal acid-base status; requires prompt resuscitation and emergent delivery if uncorrected.
Algorithmic Intrauterine Resuscitation Protocol
When intrauterine resuscitation is indicated, implement the following bundle:
- Maternal Repositioning: Turn patient to left lateral (or right lateral / hands-and-knees) to relieve aortocaval compression and alleviate cord compression.
- IV Fluid Bolus: Rapid infusion of 500 to 1,000 mL crystalloid (lactated Ringer's) to expand intravascular volume and enhance uteroplacental perfusion.
- Discontinue Uterotonics: Stop oxytocin infusions or remove dinoprostone inserts to resolve tachysystole.
- Administer Tocolytics: Give terbutaline 0.25 mg subcutaneously if tachysystole and decelerations persist.
- Supplemental Oxygen: Administer 8–10 L/min via non-rebreather mask only if maternal SpO2 <95%; routine O2 in normoxic gravidas offers no fetal benefit.
- Vaginal Examination: Palpate for rapid descent or prolapsed umbilical cord.
- Amnioinfusion: Infuse warm normal saline via IUPC for recurrent variable decelerations to cushion the cord.
A 28-year-old G1P0 at 39 weeks gestation is in active labor receiving oxytocin augmentation. Over the past 30 minutes, the uterine tocodynamometer records 7 contractions in 10 minutes. The fetal heart rate tracing demonstrates a baseline of 145 bpm, minimal variability (amplitude 3–4 bpm), and repetitive late decelerations following 80% of contractions. What is the most appropriate initial management sequence?
Increase oxytocin infusion rate to accelerate delivery and perform an immediate emergent cesarean section.
Stop oxytocin, reposition her laterally, give an IV fluid bolus, and give terbutaline 0.25 mg SC if tachysystole persists.
Place the patient in steep Trendelenburg position, administer supplemental oxygen at 2 L/min via nasal cannula, and continue current oxytocin titration.
Perform an immediate transcervical amnioinfusion of 1,000 mL normal saline and initiate vacuum-assisted vaginal delivery.
A 24-year-old G2P1 at 40 weeks gestation is in the second stage of labor, pushing actively with contractions. The continuous electronic fetal monitor demonstrates a baseline FHR of 135 bpm with moderate variability (amplitude 10–15 bpm). With each contraction, there is a gradual, symmetric decrease in FHR beginning at contraction onset, reaching a nadir of 115 bpm at the peak of the contraction, and returning to the 135 bpm baseline as the contraction resolves. Digital scalp stimulation between contractions produces an acceleration of 15 bpm for 20 seconds. How should this tracing be classified and managed?
Category I tracing showing physiologic early decelerations; continue expectant management and support pushing efforts without intrauterine resuscitation.
Category II tracing showing recurrent late decelerations; immediately discontinue labor and prepare the operative suite for emergency delivery.
Category III tracing due to vagal-induced bradycardia; perform immediate amnioinfusion and place the patient in high Fowler position.
Category II tracing showing variable decelerations; administer 0.25 mg subcutaneous terbutaline to arrest maternal pushing.
A 32-year-old G1P0 at 38 weeks gestation with severe preeclampsia is undergoing labor induction with oxytocin. The external fetal tracing reveals a baseline rate of 120 bpm with completely absent baseline variability. Over the last 40 minutes, deep late decelerations are observed after every contraction, with the nadir occurring 35 seconds after the contraction peak and delayed recovery. Maternal repositioning to left lateral and a 1,000 mL lactated Ringer's bolus fail to restore variability or resolve the decelerations. What is the correct classification and next clinical step?
Category I tracing; continue oxytocin augmentation and reassess cervical dilation in 4 hours.
Category II tracing; initiate continuous fetal scalp blood sampling every 15 minutes while awaiting spontaneous vaginal birth.
Category III tracing; it predicts abnormal fetal acid-base status and requires preparation for expedited delivery.
Category II tracing; perform vibroacoustic stimulation every 5 minutes and administer oral terbutaline.
Sections you finish are checked off in the contents.